Atria Investments Inc raised its position in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report) by 6.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 190,216 shares of the company’s stock after buying an additional 11,029 shares during the period. Atria Investments Inc’s holdings in Columbia Research Enhanced Core ETF were worth $6,998,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the company. Daymark Wealth Partners LLC lifted its position in shares of Columbia Research Enhanced Core ETF by 14.1% in the 2nd quarter. Daymark Wealth Partners LLC now owns 720,517 shares of the company’s stock worth $26,508,000 after purchasing an additional 89,024 shares during the period. PCA Investment Advisory Services Inc. lifted its position in shares of Columbia Research Enhanced Core ETF by 24.7% in the 2nd quarter. PCA Investment Advisory Services Inc. now owns 17,464 shares of the company’s stock worth $643,000 after purchasing an additional 3,460 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in shares of Columbia Research Enhanced Core ETF in the 2nd quarter worth about $841,000. Envestnet Asset Management Inc. lifted its position in shares of Columbia Research Enhanced Core ETF by 14.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 65,696 shares of the company’s stock worth $2,417,000 after purchasing an additional 8,317 shares during the period. Finally, Leavell Investment Management Inc. lifted its position in shares of Columbia Research Enhanced Core ETF by 39.5% in the 2nd quarter. Leavell Investment Management Inc. now owns 125,694 shares of the company’s stock worth $4,624,000 after purchasing an additional 35,594 shares during the period.
Columbia Research Enhanced Core ETF Trading Up 0.1%
NYSEARCA:RECS opened at $41.02 on Friday. The company has a 50-day moving average price of $39.92 and a 200-day moving average price of $37.22. Columbia Research Enhanced Core ETF has a 12 month low of $28.64 and a 12 month high of $41.64. The stock has a market cap of $4.25 billion, a price-to-earnings ratio of 22.01 and a beta of 0.95.
Columbia Research Enhanced Core ETF Company Profile
The Columbia Research Enhanced Core ETF (RECS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting. RECS was launched on Sep 25, 2019 and is managed by Columbia.
Further Reading
- Five stocks we like better than Columbia Research Enhanced Core ETF
- Following Congress Stock Trades
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- Energy and Oil Stocks Explained
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- CD Calculator: Certificate of Deposit Calculator
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Want to see what other hedge funds are holding RECS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Core ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Core ETF and related companies with MarketBeat.com's FREE daily email newsletter.
